Archive: Articles

Remember: Ours is a Consumer-Powered Economy—Powered by You
The mutually beneficial relationships between sellers and buyers are the primary drivers of our economic prosperity.
Luka Ladan | November 21, 2019
Scoot: A Player in The Urban Motorbike Surge
In an Interview With Founder Michael Keating, I Learn About the San Francisco-Based Electric Vehicle Provider, and Its Goal to Spread Across America
I spoke with Founder and President Michael Keating about what Scoot does, and its long-term plans.
Scott Beyer | November 20, 2019
Will the Courts Rein in Collegiate Race/Gender Pandering?
American University in Washington spent $121 million on “diversity” initiatives in 2018 and 2019.
Richard Vedder | November 19, 2019
The Berlin Wall Still Teaches Invaluable Lessons 30 Years After Its Fall
The fight for freedom needs to be constantly renewed.
Alvaro Vargas Llosa | November 18, 2019
Blackouts and Monopolies: Public Utilities in California
The lack of competition means there is significantly less incentive to invest in innovation, either in efficiency or safety.
Adam B. Summers | November 16, 2019
A Tale of Two Drug Approvals
The FDA has a unique responsibility to approve game-changing medications in a timely manner.
Ross Marchand | November 15, 2019
Do University Stores Rip Off Students?
Prices of surveyed goods were significantly higher at the university store than at Wal-Mart or Kroger.
Richard Vedder | November 14, 2019
Is Urban America Ready For Mopeds?
Two-Wheeled Electric Mopeds Are Another Key in our Country’s Shift to Micro-Mobility
Micro-mobility has become a nascent industry in urban areas and mopeds could soon join the trend.
Scott Beyer | November 13, 2019
Detroit Right to Literacy Ignores the Potential of School Choice
Choice in education is the more efficient way for students to achieve literacy.
Kristiana Bolzman | November 12, 2019
Breakthrough Alzheimer’s Drug Puts FDA’s Drug-Approval Process into Question
Peer-reviewed research and many case studies highlight weaknesses in the FDAs drug approval approach.
Raymond J. March | November 11, 2019